CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	38.78B -36.6%
Revenue (ttm)	2.35B +21.9%
Net Income	-308.08M
EPS	-0.22
Shares Out	1.39B
PE Ratio	n/a
Forward PE	38.28
Dividend	0.02 (0.07%)
Ex-Dividend Date	May 29, 2025

Volume	5,734,200
Open	28.85
Previous Close	27.85
Day's Range	26.91 - 28.85
52-Week Range	26.91 - 63.31
Beta	0.20
Analysts	Strong Buy
Price Target	49.13 (+80.1%)
Earnings Date	Apr 28, 2026

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,369
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765